Cancer Genetics Renegotiates Credit Agreement with Wells Fargo | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today announced a renegotiated credit agreement with Wells Fargo.

The agreement, entered into on April 1, provides Cancer Genetics with a maximum borrowing amount of $6 million, which was fully drawn as of April 1, it said in a document filed with the US Securities and Exchange Commission. The line was extended through April 1, 2016 at an interest rate of LIBOR plus 1.75 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.